Stryker launches next-gen Mako suite
March 11, 2025
Stryker (NYSE: SYK) announced today that it is commercially launching the next generation of its Mako surgical robotic platform.
Stryker (NYSE: SYK) announced today that it is commercially launching the next generation of its Mako surgical robotic platform.
Sooma Medical announced today that it received FDA investigational device exemption (IDE) for its transcranial direct current stimulation (tDCS) device.
New research from the University of Kentucky has earned a spot on the cover of the Journal of Neuroscience, highlighting a major challenge in spinal cord injury recovery.
Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and successfully eliminated 50% of the tumors in model animals. This study was led by Dr. Razan Masarwy, MD, Ph.D. from the lab of Prof. Dan Peer. The findings are published in the journal Advanced Science.
Researchers at the Francis Crick Institute have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells.